What’s in Regeneron Pharmaceuticals Inc (REGN)’s Pipes?
From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 29, 2013 - 8:37pm
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will report its earnings this Friday and dazzle investors with another strong showing for vision treatment Eylea. The company’s trading up more than 100% in the past year and has Sanofi SA (NYSE:SNY) backing many of its projects. It’s not a bad time to be Regeneron. But selecting well-rounded investments means looking [...]
Continue reading this article »
Share This Article: